View Rule

View EO 12866 Meetings

Printer-Friendly Version Download RIN Data in XML

TREAS/IRS

RIN: 1545-BM26

Publication ID: Fall 2017

Title: Branded Prescription Drug Fee
Abstract: This proposed regulation modifies the definition or the term "controlled group" in 26 CFR 51.2T.
Agency: Department of the Treasury(TREAS)	Priority: Substantive, Nonsignificant
RIN Status: Previously published in the Unified Agenda	Agenda Stage of Rulemaking: Completed Actions
Major: No	Unfunded Mandates: No
EO 13771 Designation: Other
CFR Citation: 26 CFR 51
Legal Authority: 26 U.S.C. 7805 26 U.S.C. 9008 Pub. L. 111-347 Affordable Care Act

Legal Deadline: None

Timetable:

Action	Date	FR Cite
NPRM	07/28/2014	79 FR 43699
NPRM Comment Period End	10/27/2014
Final Rule and Removal of Temporary Regulation (Completed by TD 9823)	07/26/2017	82 FR 34611
Final Rule and Removal of Temporary Regulation Effective	07/24/2017

Additional Information: REG-123286-14 Drafting attorney: Rachel S. Smith (202) 317-6855 Reviewing attorney: Charles Langley (202) 317-6855 Treasury attorney: Hannah Hawkins (202) 622-3351 CC: PSI
Regulatory Flexibility Analysis Required: No	Government Levels Affected: None
Small Entities Affected: No	Federalism: No
Included in the Regulatory Plan: No
RIN Data Printed in the FR: No
Related RINs: Related to 1545-BM27
Agency Contact: Rachel S. Smith Department of the Treasury Internal Revenue Service 1111 Constitution Avenue NW., Room 5314, Washington, DC 20224 Phone:202 317-6855 Fax:855 591-7869 Email: rachel.s.smith@irscounsel.treas.gov